Human 3 with Brom and Sam

Cybin CEO Doug Drysdale: Sublingual Psilocybin, Next-Gen Psychedelics & Brain Imaging Technology

Listen Later

Doug Drysdale is the CEO of Cybin, a psychedelic research company developing novel delivery systems for psilocybin, next-gen psychedelic  tryptamine molecules and performing studies on human brains under the influence of psychedelics using powerful brain imaging technology.  In this episode of the Integration Conversation, Brom and Doug cover all aspects of Cybin's business, and answer questions like:   

  • Why is Cybin's sublingual psilocybin potentially superior to offerings from Compass Pathways and Usona?  
  • How might deuterated tryptamines provide a superior psychedelic experience compared to classic psychedelics like psilocybin and LSD? 
  • Why is Cybin's partnership with brain imaging company Kernel so powerful?  
  • and the ultimate question for investors:  is Cybin undervalued?   


    • 👇👇👇 Links 👇👇👇  

    📺 Watch on YouTube:  https://youtu.be/cAsFHlVLpeA

    💻 The Integration Co Website:  https:/theintegration.co  

    📝 My notes on psychedelic investing:  https://brompersonal.s3-us-west-2.amazonaws.com/assets/broms-notes-psychedelic-investing.pdf   

    🎧 Listen on Spotify and other podcast platforms:  https://anchor.fm/theintegrationco  

    🐦 brom on twitter:  https://twitter.com/therealbrom  

    🎇 Clips and other stuff on Instagram:  https://instagram.com/theintegrationco  

    💌 Email:   [email protected]  


    ⏰ Timestamps: 

    • 0:00 - intro / disclaimer / disclosures  
    • 4:20 - Cybin overview / Doug background  
    • 8:50 - What are the differences between traditional pharma & psychedelic pharma?  
    • 11:30 - How will Cybin deliver its drugs?  Clinics?   
    • 13:00 - Cybin's sublingual psilocybin  
    • 15:45 - Is sublingual psilocybin as effective as normal psilocybin?  
    • 17:00 - More on Cybin and clinics  
    • 18:30 - is psychedelic decriminalization a threat to psychedelic pharma?  
    • 20:30 - Doug Drysdale on Compass Pathway's patents 
    • 22:00 - Cybin's Deuterated Tryptamines  
    • 24:30 - How does Cybin choose which drug will work for a given indication?  
    • 27:30 - What makes deuterated tryptamines different? 
    • 29:30 - Is reducing the hallucinogenic effect of psychedelics desirable?  
    • 32:00 - Cybin's inhalation and ODT delivery methods?  
    • 33:33 - Cybin's partnership with Kernel 
    • 40:00 - What are Cybin's upcoming catalysts?  
    • 42:00 - Is Cybin undervalued?  
    • 44:45 - Why is most psychedelic research being done by small startup companies?  
    • 47:00 - Is the psychedelic space overcrowded?  
    • 50:00 - Post-Interview analysis    



      • ...more
      View all episodesView all episodes
      Download on the App Store
      Human 3 with Brom and SamBy Brom Rector and Sam Tabone
      • 5
      • 5
      • 5
      • 5
      • 5

      5

      6 ratings

      More shows like Human 3 with Brom and Sam

      View all
      Freakonomics Radio by Freakonomics Radio + Stitcher

      Freakonomics Radio

      32,073 Listeners

      The Joe Rogan Experience by Joe Rogan

      The Joe Rogan Experience

      225,496 Listeners

      Odd Lots by Bloomberg

      Odd Lots

      1,795 Listeners

      Pivot by New York Magazine

      Pivot

      9,265 Listeners

      Invest Like the Best with Patrick O'Shaughnessy by Colossus | Investing & Business Podcasts

      Invest Like the Best with Patrick O'Shaughnessy

      2,287 Listeners

      The Daily by The New York Times

      The Daily

      110,824 Listeners

      The Psychedelic Podcast by Third Wave

      The Psychedelic Podcast

      298 Listeners

      My First Million by Hubspot Media

      My First Million

      2,619 Listeners

      The Prof G Pod with Scott Galloway by Vox Media Podcast Network

      The Prof G Pod with Scott Galloway

      5,361 Listeners

      All-In with Chamath, Jason, Sacks & Friedberg by All-In Podcast, LLC

      All-In with Chamath, Jason, Sacks & Friedberg

      9,216 Listeners

      Dwarkesh Podcast by Dwarkesh Patel

      Dwarkesh Podcast

      424 Listeners

      Business Trip by Greg Kubin & Matias Serebrinsky

      Business Trip

      51 Listeners

      Hard Fork by The New York Times

      Hard Fork

      5,437 Listeners

      The Ezra Klein Show by New York Times Opinion

      The Ezra Klein Show

      15,363 Listeners

      Honestly with Bari Weiss by The Free Press

      Honestly with Bari Weiss

      8,560 Listeners